Clinic
Total Urgent Care, PLLC
Total Urgent Care, PLLC was paid $1.45M by Medicaid between Jan 2019 and Dec 2024, across 29 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 49% of everything it billed.
33Billing provider infoTOTAL URGENT CARE, PLLC
IMLAY CITY, MI 48444
IMLAY CITY, MI 48444
33aNPI1073036810assigned 07/24/2017
33bProvider typeUrgent Care Clinic/Center
28Total paid$1.45M
24GClaims33,489
24DCodes billed29
24AFirst – last monthJan 2019 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Michigan
Rank by total paid#48 of 239
Median peer was paid$346K
This provider vs. median4.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 913 | $43K | |
| 2020 | 2,132 | $102K | |
| 2021 | 10,900 | $472K | |
| 2022 | 10,184 | $417K | |
| 2023 | 5,469 | $244K | |
| 2024incomplete | 3,891 | $172K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 49% | 12,766 | 11,374 | $711K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 24% | 5,442 | 5,422 | $354K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 9.4% | 3,474 | 3,242 | $137K |
| 86328 | 3.9% | 1,625 | 1,534 | $57K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.4% | 657 | 625 | $49K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.9% | 1,758 | 1,688 | $42K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 2.0% | 1,015 | 946 | $29K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.5% | 1,646 | 1,024 | $22K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 1,407 | 1,386 | $15K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,415 | 1,348 | $13K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 91 | 89 | $8K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 132 | 131 | $4K |
17 more codes
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 652 | $3K |
| 81002 | <1% | 636 | $2K | |
| 87807 | <1% | 177 | $1K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 13 | $527.67 |
| 86318 | <1% | 32 | $464.38 | |
| 87400 | <1% | 63 | $444.60 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 127 | $308.75 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 64 | $282.92 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 150 | $261.46 |
| J1020 | Injection, methylprednisolone acetate, 20 mg | <1% | 15 | $253.80 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 29 | $152.91 |
| 87276 | <1% | 26 | $106.40 | |
| 87420 | <1% | 12 | $92.16 | |
| 87275 | <1% | 26 | $81.20 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 12 | $6.21 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 12 | $0.00 |
| S9083 | Global fee urgent care centers | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAKHTAR, JABIR (OWNER)